Cargando…

Development and Validation of Prognostic Nomograms for Elderly Patients with Osteosarcoma

BACKGROUND: The aim of the current study was to construct prognostic nomograms for individual risk prediction in elderly patients with osteosarcoma. METHODS: Data for 816 elderly patients (≥40 years old) with osteosarcoma between 2004 and 2016 from the Surveillance, Epidemiology, and End Results (SE...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaoqiang, He, Shaoya, Yao, Xi, Hu, Tianyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449646/
https://www.ncbi.nlm.nih.gov/pubmed/34548809
http://dx.doi.org/10.2147/IJGM.S331623
_version_ 1784569458918948864
author Liu, Xiaoqiang
He, Shaoya
Yao, Xi
Hu, Tianyang
author_facet Liu, Xiaoqiang
He, Shaoya
Yao, Xi
Hu, Tianyang
author_sort Liu, Xiaoqiang
collection PubMed
description BACKGROUND: The aim of the current study was to construct prognostic nomograms for individual risk prediction in elderly patients with osteosarcoma. METHODS: Data for 816 elderly patients (≥40 years old) with osteosarcoma between 2004 and 2016 from the Surveillance, Epidemiology, and End Results (SEER) database were randomly assigned to training (N=573) and internal validation (N=243) sets. The essential clinical predictors were identified based on least absolute shrinkage and selection operator (Lasso) Cox regression. Nomograms were constructed to predict the 1-, 3-, and 5-year cancer-specific survival (CSS) and overall survival (OS). RESULTS: Our LASSO regression analyses of the training set yielded five clinicopathological features (age, chemotherapy, surgery, AJCC stage, and summary stage) in the training cohort for the prognosis of elderly patients with osteosarcoma, while grade was only associated with OS and M stage was only associated with CSS. Construction of nomograms based on these predictors was performed to evaluate the prognosis of elderly patients with osteosarcoma. The C-index, calibration and decision curve analysis also showed the satisfactory performance of these nomograms for prognosis prediction. CONCLUSION: The constructed nomograms are helpful tools for exactly predicting the prognosis of elderly patients with osteosarcoma, which could enable patients to be more accurately managed in clinical practice.
format Online
Article
Text
id pubmed-8449646
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-84496462021-09-20 Development and Validation of Prognostic Nomograms for Elderly Patients with Osteosarcoma Liu, Xiaoqiang He, Shaoya Yao, Xi Hu, Tianyang Int J Gen Med Original Research BACKGROUND: The aim of the current study was to construct prognostic nomograms for individual risk prediction in elderly patients with osteosarcoma. METHODS: Data for 816 elderly patients (≥40 years old) with osteosarcoma between 2004 and 2016 from the Surveillance, Epidemiology, and End Results (SEER) database were randomly assigned to training (N=573) and internal validation (N=243) sets. The essential clinical predictors were identified based on least absolute shrinkage and selection operator (Lasso) Cox regression. Nomograms were constructed to predict the 1-, 3-, and 5-year cancer-specific survival (CSS) and overall survival (OS). RESULTS: Our LASSO regression analyses of the training set yielded five clinicopathological features (age, chemotherapy, surgery, AJCC stage, and summary stage) in the training cohort for the prognosis of elderly patients with osteosarcoma, while grade was only associated with OS and M stage was only associated with CSS. Construction of nomograms based on these predictors was performed to evaluate the prognosis of elderly patients with osteosarcoma. The C-index, calibration and decision curve analysis also showed the satisfactory performance of these nomograms for prognosis prediction. CONCLUSION: The constructed nomograms are helpful tools for exactly predicting the prognosis of elderly patients with osteosarcoma, which could enable patients to be more accurately managed in clinical practice. Dove 2021-09-14 /pmc/articles/PMC8449646/ /pubmed/34548809 http://dx.doi.org/10.2147/IJGM.S331623 Text en © 2021 Liu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Liu, Xiaoqiang
He, Shaoya
Yao, Xi
Hu, Tianyang
Development and Validation of Prognostic Nomograms for Elderly Patients with Osteosarcoma
title Development and Validation of Prognostic Nomograms for Elderly Patients with Osteosarcoma
title_full Development and Validation of Prognostic Nomograms for Elderly Patients with Osteosarcoma
title_fullStr Development and Validation of Prognostic Nomograms for Elderly Patients with Osteosarcoma
title_full_unstemmed Development and Validation of Prognostic Nomograms for Elderly Patients with Osteosarcoma
title_short Development and Validation of Prognostic Nomograms for Elderly Patients with Osteosarcoma
title_sort development and validation of prognostic nomograms for elderly patients with osteosarcoma
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449646/
https://www.ncbi.nlm.nih.gov/pubmed/34548809
http://dx.doi.org/10.2147/IJGM.S331623
work_keys_str_mv AT liuxiaoqiang developmentandvalidationofprognosticnomogramsforelderlypatientswithosteosarcoma
AT heshaoya developmentandvalidationofprognosticnomogramsforelderlypatientswithosteosarcoma
AT yaoxi developmentandvalidationofprognosticnomogramsforelderlypatientswithosteosarcoma
AT hutianyang developmentandvalidationofprognosticnomogramsforelderlypatientswithosteosarcoma